US Stock Insider Trading | VSee Health disclosed three insider transactions on March 5

K-LinePoet · 2026-04-07T02:18:03+00:00

On March 5, 2026, VSee Health disclosed insider trading activity, with Director FAIRFAX CYDONII V. purchasing 40.1k shares on March 4. Additionally, the table lists recent buying and selling transactions by several directors. VSee is a company that provides a no-code telemedicine SaaS platform.

K-LinePoet

2026-04-07 02:18:03

Abstract generation in progress

On March 5, 2026, VSee Health (VSEE) disclosed three transactions involving company insiders. Director FAIRFAX CYDONII V. purchased 40.1k shares on March 4, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Trade Price per Share/USD	Total Amount/USD
March 5, 2026	Director	FAIRFAX CYDONII V.、LOWDERMILK KEVIN、WICKERSHAM DAVID L.	March 4, 2026	Buy	120.3k	0.37	45k
February 25, 2026	Director	WICKERSHAM DAVID L.	February 23, 2026	Buy	105.3k	0.65	68.4k
February 25, 2026	Director	WICKERSHAM DAVID L.	February 23, 2026	Buy	759.9k	0.32	243.2k
February 19, 2026	Director	WICKERSHAM DAVID L.	August 14, 2025	Buy	100k	2.00	200k
February 19, 2026	Director	Aisiku Imoigele	August 15, 2025	Sell	125k	2.00	250k
January 16, 2026	Director	LOWDERMILK KEVIN、METZGER SCOTT、O’SULLIVAN COLIN P.	September 19, 2025	Buy	681	2.31	1573.11
January 16, 2026	Director	FAIRFAX CYDONII V.、LOWDERMILK KEVIN、METZGER SCOTT、O’SULLIVAN COLIN P.、WICKERSHAM DAVID L.	September 19, 2025	Buy	50.3k	1.49	75k
January 16, 2026	Director	FAIRFAX CYDONII V.、LOWDERMILK KEVIN、METZGER SCOTT、O’SULLIVAN COLIN P.、WICKERSHAM DAVID L.	September 19, 2025	Buy	109.4k	0.69	75.5k
January 16, 2026	Director	FAIRFAX CYDONII V.、LOWDERMILK KEVIN、METZGER SCOTT、O’SULLIVAN COLIN P.、WICKERSHAM DAVID L.	September 19, 2025	Buy	64.7k	1.16	75k
January 16, 2026	Director	FAIRFAX CYDONII V.、LOWDERMILK KEVIN、METZGER SCOTT、O’SULLIVAN COLIN P.、WICKERSHAM DAVID L.	September 19, 2025	Buy	62.5k	1.20	75k

[Company Profile]

VSee Health, Inc. was registered as a Delaware corporation on March 30, 2021. The company is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telemedicine workflows without programming. VSee’s system allows telemedicine mobile applications to be created within a few days or telemedicine systems to be integrated into existing hospital operations.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.